抗体依赖性增强
病毒学
登革热病毒
黄病毒
病毒
生物
病毒性脑炎
黄病毒科
登革热
病毒进入
受体
补体受体
黄热病
单克隆抗体
促炎细胞因子
病毒复制
免疫系统
抗体
病毒生命周期
病毒感染
接种疫苗
免疫学
病毒包膜
先天免疫系统
Fc受体
信号转导
病毒蛋白
日本脑炎
病毒病机
病毒载量
作者
Alexander Filatov,Maria G. Byazrova,Maria M. Sukhova,Alexey G. Prilipov
出处
期刊:Biokhimiya
[Pleiades Publishing]
日期:2026-01-01
卷期号:91 (1): 39-47
标识
DOI:10.1134/s0006297925602795
摘要
Antibody-dependent enhancement (ADE) of infection is a phenomenon observed during secondary infection caused by some viruses (primarily, from the Flaviviridae family), including dengue virus (DENV), Zika virus (ZIKV), West Nile virus (WNV), tick-borne encephalitis virus, yellow fever virus, and some others. There are two types of ADE mediated by (i) Fc receptors and (ii) receptors for complement system components. The first type involves 4 types of Fc receptors for IgG molecules (FcRI, FcRIIa, FcRIIb, and FcRIIIa) which ensure the binding of the virus-antibody complex to the target cell and its subsequent internalization. The Fc-mediated uptake of the virus is an active process that involves a number of signaling molecules and triggers branched cascades of activation events. The Fc-mediated pathway of viral entry increases the viral load and switches the cell from the antiviral response to the proinflammatory pathway, thus promoting more efficient viral replication. Unlike other Fc receptors, FcRIIb bound to IgG inhibits the capture of the virus-antibody complex and prevents the ADE. The development of ADE in response to vaccination is highly undesirable. Understanding the biochemical mechanisms underlying ADE is important for the development of new vaccines and therapeutic monoclonal antibodies for protecting against viral infections.
科研通智能强力驱动
Strongly Powered by AbleSci AI